$Cardiac metabolism in patients with heart failure with mid-range ejection fraction$

Cardiac metabolism in patients with heart failure with mid-range ejection fraction

Bibliografski detalji
Glavni autori:	Hundertmark, M, Rodgers, C, Rider, O, Neubauer, S, Mahmod, M
Format:	Conference item
Izdano:	BMJ Publishing Group 2018

Slični predmeti

Myocardial Metabolism in Heart Failure with Preserved Ejection Fraction
od: Henry, JA, i dr.
Izdano: (2024)

Intentional weight loss as a novel treatment for heart failure with preserved ejection fraction
od: Hundertmark, MJ, i dr.
Izdano: (2021)

Impaired myocardial energetics limits cardiac functional reserve and leads to exercise-induced pulmonary congestion in heart failure with preserved ejection fraction
od: Burrage, M, i dr.
Izdano: (2021)

Energetic basis for exercise-induced pulmonary congestion in heart failure with preserved ejection fraction
od: Burrage, MK, i dr.
Izdano: (2021)

Cardiac energetics in patients with aortic stenosis and preserved versus reduced ejection fraction
od: Peterzan, MA, i dr.
Izdano: (2020)

Heart failure with preserved ejection fraction
od: Harper, A, i dr.
Izdano: (2018)

Deep learning predicts heart failure with preserved, mid-range, and reduced left ventricular ejection fraction from patient clinical profiles
od: Alkhodari, M, i dr.
Izdano: (2021)

Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials
od: Cleland, J, i dr.
Izdano: (2017)

Response by Peterzan et al to letter regarding article, “Cardiac energetics in patients with aortic stenosis and preserved versus reduced ejection fraction”
od: Peterzan, MA, i dr.
Izdano: (2020)

Prevalence of heart failure preserved ejection fraction in the community
od: Mahadevan, G, i dr.
Izdano: (2007)

Myocardial energetic impairment is the basis for reduced cardiac reserve and exercise-induced pulmonary congestion in heart failure with preserved ejection fraction: insights from novel cardiopulmonary magnetic resonance imaging
od: Burrage, MK, i dr.
Izdano: (2021)

The interplay between metabolic alterations, diastolic strain rate and exercise capacity in mild heart failure with preserved ejection fraction: a cardiovascular magnetic resonance study
od: Mahmod, M, i dr.
Izdano: (2018)

Device-Based Solutions to Improve Cardiac Physiology and Hemodynamics in Heart Failure With Preserved Ejection Fraction
od: Rosalia, Luca, i dr.
Izdano: (2022)

Design and rationale of the EMPA-VISION trial: investigating the metabolic effects of empagliflozin in patients with heart failure
od: Hundertmark, MJ, i dr.
Izdano: (2021)

Assessment of cardiac energy metabolism, function, and physiology in patients with heart failure taking empagliflozin: the randomized, controlled EMPA-VISION trial
od: Hundertmark, MJ, i dr.
Izdano: (2023)

Response to letter regarding article, "The effect of selective heart rate slowing in heart failure with preserved ejection fraction"
od: Pal, N, i dr.
Izdano: (2016)

Diagnosis of patients with heart failure with preserved ejection fraction in primary care: cohort study
od: Forsyth, F, i dr.
Izdano: (2021)

Derangement of cardiac high energy phosphate metabolism in patients with left ventricular non-compaction and preserved ejection fraction
od: Petersen, S, i dr.
Izdano: (2006)

Use of cardiac magnetic resonance to detect changes in metabolism in heart failure
od: Watson, WD, i dr.
Izdano: (2020)

Pirfenidone in heart failure with preserved ejection fraction—rationale and design of the PIROUETTE trial
od: Lewis, G, i dr.
Izdano: (2019)

Characteristics of patients with heart failure with preserved ejection fraction in primary care: Cross-sectional analysis
od: Forsyth, F, i dr.
Izdano: (2021)

Clinical and echocardiographic characteristics and cardiovascular outcomes according to diabetes status in patients with heart failure and preserved ejection fraction. A report from the Irbesartan in Heart Failure with Preserved Ejection Fraction trial (I-Preserve)
od: Kristensen, S, i dr.
Izdano: (2017)

A comparison of visual and quantitative assessment of left ventricular ejection fraction by cardiac magnetic resonance
od: Holloway, C, i dr.
Izdano: (2011)

A comparison of visual and quantitative assessment of left ventricular ejection fraction by cardiac magnetic resonance.
od: Holloway, C, i dr.
Izdano: (2011)

Erratum to: A comparison of visual and quantitative assessment of left ventricular ejection fraction by cardiac magnetic resonance.
od: Holloway, C, i dr.
Izdano: (2011)

Multiparametric cardiovascular magnetic resonance for the assessment of cardiac function and metabolism in hypertrophy and heart failure
od: Mahmod, M
Izdano: (2013)

Understanding the management of heart failure with preserved ejection fraction: a qualitative multiperspective study
od: Sowden, E, i dr.
Izdano: (2020)

Risk Related to Pre–Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction
od: Kristensen, S, i dr.
Izdano: (2016)

Impaired active relaxation during dynamic exercise in patients with heart failure with a preserved ejection fraction (HfpEF)
od: Phan, T, i dr.
Izdano: (2008)

A hyperdynamic RV is an early marker of clinical decompensation and cardiac recovery in aortic stenosis with normal LV ejection fraction
od: Rigolli, M, i dr.
Izdano: (2018)

Phenogrouping heart failure with preserved or mildly reduced ejection fraction using electronic health record data
od: Soltani, F, i dr.
Izdano: (2024)

Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis
od: Kotecha, D, i dr.
Izdano: (2016)

Using multi-parametric imaging and multi-nuclear cardiac magnetic resonance to investigate novel treatment strategies for heart failure
od: Hundertmark, MJ
Izdano: (2022)

Investigating cardiac energetics in heart failure.
od: Lygate, C, i dr.
Izdano: (2013)

Investigating cardiac energetics in heart failure
od: Lygate, C, i dr.
Izdano: (2013)

Effects of chronic beta-receptor blocker treatment on cardiac high-energy phosphate metabolism in heart failure
od: Neubauer, S
Izdano: (2000)

Cardiac dysfunction and development of heart failure.
od: Ertl, G, i dr.
Izdano: (1993)

Cost Evaluation Of Heart Failure Treatment, Cost-effectiveness Analysis And Budget Impact Of Adding Empagliflozin To Standard Treatment For Heart Failure With Reduced Ejection Fraction
od: Low, Joo Zheng
Izdano: (2023)

DYNAMIC CHANGES IN LEFT VENTRICULAR FUNCTION ON EXERCISE IN HEART FAILURE WITH PRESERVED EJECTION FRACTION: THE ROLE OF MYOCARDIAL ENERGY DEFICIENCY
od: Phan, T, i dr.
Izdano: (2009)

Opposite correlations of cardiac palmitate oxidation rates and plasma free fatty acids with ejection fractions in the infarcted rat heart
od: Catchpole, A, i dr.
Izdano: (2008)